FDA approves Wegovy weight-loss shot for heart disease patients - including those who are not obese
The FDA approved the medication for this use in non-diabetic patients who had heart disease today, following clinical trials showing it slashed the risk of the complications by up to 28 percent.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cardiology | Clinical Trials | Diabetes | Eating Disorders & Weight Management | Endocrinology | Health | Heart | Heart Disease | Obesity | Weight Loss